Colossal

Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction.

Health and bio

Colossal raised $120M in a funding round announced September 18, 2025, according to bloomberg.com. Across 2 sourced rounds it has raised $320M in total. Investors in that round: Breyer Capital.

Raise history

1. September 29, 2026
   First seen by Recent Funding
   via startups.gallery
2. September 18, 2025
   Round · $120M
   BBreyer Capital (lead)
   Source: bloomberg.com (startups.gallery listing)
3. January 15, 2025
   Series B+ · $200M
   TTWG Global (lead)
   Source: businesswire.com (startups.gallery listing)

Investors

• BBreyer Capital
• TTWG Global

Related other companies

• QQuartermaster$140M · Sep 28, 2026
• SSnorkel AI$350M · Sep 23, 2026
• EEnveda$311M · Sep 23, 2026
• HHeidi Health$100M · Sep 22, 2026
• FFirecrawl$75M · Sep 22, 2026
• CCorridor$25M · Sep 21, 2026
• JJack & Jill$40M · Sep 19, 2026
• MMithr Inc.$20M · Sep 19, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/colossal.